These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37237491)

  • 21. Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.
    Saetersmoen ML; Hammer Q; Valamehr B; Kaufman DS; Malmberg KJ
    Semin Immunopathol; 2019 Jan; 41(1):59-68. PubMed ID: 30361801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products.
    Sadeqi Nezhad M; Abdollahpour-Alitappeh M; Rezaei B; Yazdanifar M; Seifalian AM
    Pharm Res; 2021 Jun; 38(6):931-945. PubMed ID: 34114161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells.
    Hsu LJ; Liu CL; Kuo ML; Shen CN; Shen CR
    Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of "Off-the-Shelf" Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells.
    Zeng J; Tang SY; Toh LL; Wang S
    Stem Cell Reports; 2017 Dec; 9(6):1796-1812. PubMed ID: 29173894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Ethanol Extract of
    Kim A; Baek SJ; Shin S; Lee SY; Chung SK
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting.
    Goldenson BH; Hor P; Kaufman DS
    Front Immunol; 2022; 13():841107. PubMed ID: 35185932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient Killing of Murine Pluripotent Stem Cells by Natural Killer (NK) Cells Requires Activation by Cytokines and Partly Depends on the Activating NK Receptor NKG2D.
    Gröschel C; Hübscher D; Nolte J; Monecke S; Sasse A; Elsner L; Paulus W; Trenkwalder C; Polić B; Mansouri A; Guan K; Dressel R
    Front Immunol; 2017; 8():870. PubMed ID: 28890717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells.
    Maddineni S; Silberstein JL; Sunwoo JB
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gingival Fibroblasts as Autologous Feeders for Induced Pluripotent Stem Cells.
    Yu G; Okawa H; Okita K; Kamano Y; Wang F; Saeki M; Yatani H; Egusa H
    J Dent Res; 2016 Jan; 95(1):110-8. PubMed ID: 26467419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a Murine Tumor Rejection Model.
    Gąbka-Buszek A; Kwiatkowska-Borowczyk E; Jankowski J; Kozłowska AK; Mackiewicz A
    Vaccines (Basel); 2020 Mar; 8(2):. PubMed ID: 32224883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.
    Rivera T; Zhao Y; Ni Y; Wang J
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e117. PubMed ID: 32649060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced wound healing promotion by immune response-free monkey autologous iPSCs and exosomes vs. their allogeneic counterparts.
    Lu M; Peng L; Ming X; Wang X; Cui A; Li Y; Wang X; Meng D; Sun N; Xiang M; Chen S
    EBioMedicine; 2019 Apr; 42():443-457. PubMed ID: 30926422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of mice derived from induced pluripotent stem cells.
    Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
    J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells.
    Watarai H; Fujii S; Yamada D; Rybouchkin A; Sakata S; Nagata Y; Iida-Kobayashi M; Sekine-Kondo E; Shimizu K; Shozaki Y; Sharif J; Matsuda M; Mochiduki S; Hasegawa T; Kitahara G; Endo TA; Toyoda T; Ohara O; Harigaya K; Koseki H; Taniguchi M
    J Clin Invest; 2010 Jul; 120(7):2610-8. PubMed ID: 20516640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease.
    Son MY; Lee MO; Jeon H; Seol B; Kim JH; Chang JS; Cho YS
    Exp Mol Med; 2016 May; 48(5):e232. PubMed ID: 27174201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy.
    Aoki T; Motohashi S; Koseki H
    Inflamm Regen; 2023 May; 43(1):27. PubMed ID: 37170375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of marker genes to monitor residual iPSCs in iPSC-derived products.
    Lemmens M; Perner J; Potgeter L; Zogg M; Thiruchelvam S; Müller M; Doll T; Werner A; Gilbart Y; Couttet P; Martus HJ; Libertini S
    Cytotherapy; 2023 Jan; 25(1):59-67. PubMed ID: 36319564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of antigen-receptor modified allogeneic T cell from iPS cells for cancer immunotherapy].
    Kaneko S
    Rinsho Ketsueki; 2022; 63(9):1279-1289. PubMed ID: 36198554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human iPSC-Derived Renal Cells Change Their Immunogenic Properties during Maturation: Implications for Regenerative Therapies.
    Rossbach B; Hariharan K; Mah N; Oh SJ; Volk HD; Reinke P; Kurtz A
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.